Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,462.60 | 40.90 | 0.49% |
CAC 40 | 7,747.09 | 52.65 | 0.68% |
DAX 40 | 23,501.21 | 148.52 | 0.64% |
Dow JONES (US) | 41,308.58 | 59.87 | -0.14% |
FTSE 100 | 8,554.83 | 23.22 | 0.27% |
HKSE | 22,867.74 | 91.82 | 0.40% |
NASDAQ | 17,962.70 | 34.56 | 0.19% |
Nikkei 225 | 37,503.33 | 574.70 | 1.56% |
NZX 50 Index | 12,605.07 | 138.04 | 1.11% |
S&P 500 | 5,668.41 | 4.47 | 0.08% |
S&P/ASX 200 | 8,231.20 | 39.50 | 0.48% |
SSE Composite Index | 3,342.00 | 10.00 | -0.30% |